TO ANALYZING HEMODYNAMIC CHANGES IN PENILE DOPPLER, COMPARING SILDENAFIL AND PAPAVERINE.

Background: A lot of people come to us complaining about erectile dysfunction. These days, even those under the age of 30 frequently deal with the problem of early onset hypertension and diabetes. Material and Methods: The study comprised 70 consecutive patients who were referred from several departments, including general medical outpatient, psychiatry, diabetology, and urology. This study was conducted at the Department of Radiology, Sri Balaji Medical College. Renigunta, Tirupati, Andhra Pradesh, India between March 2023 to Jan 2024. Every patient complained of erectile dysfunction for at least half a year. A thorough clinical history and basic blood chemistry were performed on each subject. Results: These are a few instances of venous and arterial insufficiency patterns associated with erectile dysfunction. The individuals' ages ranged from 22 to 65 years old, with a mean age of 44. The average score of the 70 subjects on the SHIM questionnaire was 14.6. About 30% of the participants had no identified risk factors, despite the fact that diabetes and hypertension were the primary causes in the great majority of instances. Out of 70 participants, 56 responded normally to sildenafil and 59 to papaverine. Papaverine found that 21 individuals taking sildenafil had erectile dysfunction, compared to 18 who did not. Conclusion: Tab. Sildenafil significantly increases blood flow to the penile vasculature, according to the study, suggesting it may be useful as an erectogenic agent in penile Doppler studies when paired with self-tactile stimulation. [ABSTRACT FROM AUTHOR]